Physician profile
August D Accetta
NPI 1265506893
$1,680.81
in general payments reported to CMS, 2019-2025
16 companies · $103 in 2025
The $103 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $280 · 2020: $225 · 2021: $95.33 · 2022: $401 · 2023: $380 · 2024: $197 · 2025: $103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $679.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $679.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $600.21 | 2019-2023 | Lo Loestrin Fe, Orilissa, Ubrelvy |
| Sumitomo Pharma America, INC. | $195.72 | 2023-2025 | Myfembree, Gemtesa |
| Organon LLC | $187.16 | 2021-2025 | Nexplanon |
| Merck Sharp & Dohme LLC | $125.79 | 2019-2021 | |
| Pfizer INC. | $113.36 | 2023-2024 | |
| Therapeuticsmd, INC. | $106.52 | 2019-2022 | |
| Hologic Sales and Service, LLC | $93.40 | 2019-2024 | Novasure, Myosure Tissue Removal Device, Acessa Provu System |
| Bayer Healthcare Pharmaceuticals INC. | $73.50 | 2020-2023 | |
| Agile Therapeutics, INC. | $44.74 | 2022-2024 | Twirla |
| Ferring Pharmaceuticals INC. | $31.31 | 2019 | |
| Novo Nordisk INC | $21.06 | 2024 | Wegovy |
| Roche Diagnostics Corporation | $20.61 | 2019 | |
| Evofem Biosciences, INC. | $19.53 | 2024 | |
| Myovant Sciences INC. | $18.14 | 2022 | |
| Shield Therapeutics INC | $15.42 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $14.34 | 2024 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw August Accetta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.